Amanote Research
Register
Sign In
Genetic Variation as a Modifier of Association Between Therapeutic Exposure and Subsequent Malignant Neoplasms in Cancer Survivors
Cancer
- United States
doi 10.1002/cncr.29096
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 29, 2014
Authors
Smita Bhatia
Publisher
Wiley
Related search
Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Subsequent Neoplasms of the CNS Among Survivors of Childhood Cancer: A Systematic Review
The Lancet Oncology
Oncology
Genetic Variation in POT1 and Risk of Thyroid Subsequent Malignant Neoplasm: A Report From the Childhood Cancer Survivor Study
PLoS ONE
Multidisciplinary
Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors
Clinical Cancer Research
Cancer Research
Oncology
Subsequent Malignant Neoplasms in Pediatric Patients Initially Diagnosed With Neuroblastoma
Journal of Pediatric Hematology/Oncology
Child Health
Oncology
Pediatrics
Hematology
Perinatology
αB-crystallin: Portrait of a Malignant Chaperone as a Cancer Therapeutic Target
Pharmacology and Therapeutics
Pharmacology
Therapeutic Work as a Facilitator for Return to Paid Work in Cancer Survivors
Journal of Occupational Rehabilitation
Occupational Therapy
Rehabilitation
Combined Risk of Second Malignant Neoplasms and Cardiovascular Disease in Long-Term Hodgkin Lymphoma Survivors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Genome-Wide Association Study of N370S Homozygous Gaucher Disease Reveals the Candidacy of CLN8 Gene as a Genetic Modifier Contributing to Extreme Phenotypic Variation
American Journal of Hematology
Hematology
